Enriqueta Felip Font
- Position: Director
- Type: Independent
- First appointment: 24/05/19
- Re-elections: 16/6/23
- Last appointment: 16/6/23
Dr. Enriqueta Felip Font has served as director of Grifols S.A. since May 2019. She received her degree in Medicine and Surgery from the Autonomous University of Barcelona (UAB), where she also completed her studies for a PhD in Medical Oncology. She has been an Associate Professor at the UAB from 2010 to May 2019. She is nowadays, Professor of Medicine at the Universitat de Vic (UVicc-UCC). She has an extensive professional career and accredited experience in the oncology sector, as well as knowledge in the scientific and research field. She is currently the Section Chief of the Medical Oncology Service at Vall d'Hebron University Hospital and the Principal Investigator of the Vall d'Hebron Institute of Oncology's Thoracic Tumors and Head and Neck Cancer Group.
Ms. Enriqueta Felip Font has made significant contributions to cancer research, especially in the field of thoracic tumors, and has collaborated in the development of lung cancer approaches that define the current standard of care for the disease. Dr Felip has been involved in several initiatives with scientific organizations, among them, as member of the Board of Directors of the International Association for the Study of Lung Cancer (IASLC, 2017-2021).
She is currently the President of the Oncology Comission at Vall d’Hebron University Hospital and she is member of the Scientific Committee of the Institut d'Investigació i Innovació Parc Taulí. Throughout her career, she has obtained several recognitions for her work in the oncology field. In 2015, she was awarded with the first Women for Oncology Award from the European Society of Medical Oncology (ESMO). Recently she has been awarded with the Prize “La Vanguardia de la Ciencia” (May 2022). Dr Felip featured on Clarivate Analytics' annual Global Highly Cited Researchers List 2018, 2019, 2020, 2021, 2022 and 2023. Ms. Enriqueta Felip Font has authored more than 350 peer-reviewed manuscripts. Her professional background has provided her with expertise and knowledge on scientific and innovation matters.